The Scales of American Justice Keep Tilting Toward China

A Chinese biotech company, WuXi AppTec, won a preliminary injunction against the Pentagon's attempt to blacklist it from U.S. military contracts. The ruling exposes a vulnerability in the U.S. political system, as institutions can sometimes protect adversaries. The Defense Department cited WuXi AppTec's involvement in China's military modernization strategy, but a federal judge blocked the measures, citing lack of evidence.

This victory for WuXi AppTec follows other instances where Chinese companies have successfully challenged U.S. government actions in court. The asymmetry in power between the U.S. and China extends beyond one biotech company, as both countries compete in sanctions, tariffs, intellectual property, and national security cases. While Washington faces constraints from courts and due process, Beijing, an authoritarian rival, lacks similar limitations.

China experts suggest that Beijing actively seeks to redefine democracy on its terms, posing a threat to American-style democracy. The struggle for technological leadership could further widen the asymmetry, with potential consequences for U.S. companies and their ability to operate in China.